+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain Drug"

From
From
Pregabalin Market 2022-2026 - Product Thumbnail Image

Pregabalin Market 2022-2026

  • Report
  • September 2022
  • 120 Pages
  • Global
From
From
From
From
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 - Product Thumbnail Image

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

  • Report
  • November 2021
  • 70 Pages
  • Global
From
Market Spotlight: Neuropathic Pain - Product Thumbnail Image

Market Spotlight: Neuropathic Pain

  • Report
  • February 2021
  • 35 Pages
  • Global
From
From
Loading Indicator

The Neuropathic Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathic pain drugs are used to treat chronic pain caused by nerve damage, such as diabetic neuropathy, postherpetic neuralgia, and trigeminal neuralgia. These drugs are typically divided into two categories: anticonvulsants and antidepressants. Anticonvulsants are used to reduce the intensity of nerve pain, while antidepressants are used to reduce the frequency of nerve pain. Commonly prescribed neuropathic pain drugs include pregabalin, gabapentin, duloxetine, and amitriptyline. Some companies in the Neuropathic Pain Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and Novartis. Show Less Read more